Oxyquinoline: CIR Safety Assessment Summary
CIR safety assessment summary for Oxyquinoline: ingredients reviewed, panel verdict, use concentration context, conditions, and source citation.
Oxyquinoline appears in a CIR safety assessment covering Oxyquinoline, Oxyquinoline Sulfate. The panel verdict for the report is safe_with_qualifications. Based on the available information, the CIR Expert Panel concludes that Oxyquinoline and Oxyquinoline Sulfate are safe as used as stabilizers for hydrogen peroxide in leave-on hair care cosmetic products. There are insufficient data to support the safety of Oxyquinoline and Oxyquinoline Sulfate in leave-on cosmetic products.
| Field | CIR value |
|---|---|
| Primary ingredient | Oxyquinoline |
| CIR verdict | safe_with_qualifications |
| Report type | Final Amended Report |
| Date | 2006 |
| CAS numbers | 148-24-3, 131-31-6 |
| Conditions or carve-outs |
Ingredients Reviewed
The review scope matters because CIR conclusions often apply to an ingredient family rather than a single INCI name. In this report, the ingredient list includes Oxyquinoline, Oxyquinoline Sulfate.
Safety Conclusion
The conclusion for Oxyquinoline should be read as a CIR panel conclusion, not a regulatory limit. CIR assessments summarize expert-panel safety determinations for cosmetic use, while legal status still depends on the jurisdiction and product category.
Conditions
Based on the available information, the CIR Expert Panel concludes that Oxyquinoline and Oxyquinoline Sulfate are safe as used as stabilizers for hydrogen peroxide in leave-on hair care cosmetic products.
Formulation Reading
For formula review, begin with the exact INCI identity and the ingredient group covered by the CIR assessment. If the material is Oxyquinoline, the relevant comparison is whether the intended use aligns with the practices, concentration ranges, and conditions described in the CIR source.
The ingredient hub at Oxyquinoline should carry the substance-level profile. This page is the report-level summary, keeping the conclusion, ingredient scope, and use-context language attached to the CIR source rather than treating the conclusion as a universal permission.
Why This Page Exists
CIR reviews are long documents, and the practical answer is usually buried in the conclusion and the table of current practices. This summary keeps those CIR facts in one indexable page for Oxyquinoline, with source details retained at the bottom for audit.
Review Notes
The conservative reading is to keep Oxyquinoline tied to the exact CIR report listed below. The ingredient family, panel conclusion, date, and any use-condition language belong together. A shorter ingredient-page snippet would lose that context.
This page gives the search-level answer while preserving the source-level caveat: CIR safety language is a panel assessment for cosmetic practices of use, not a universal legal permission across every jurisdiction or product category.
Source
- CIR report: Final Amended Report on the Safety Assessment of Oxyquinoline and Oxyquinoline Sulfate as Used in Cosmetics
- CIR source file: PRS387.pdf
- Extraction JSON: CIR Safety Assessment Database
- Conclusion page in CIR extraction: 8